EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.1.1.10 | 1-[3-[(3,5-dibromobenzyl)amino]propyl]-3-phenylurea | - |
Enterococcus faecalis | |
6.1.1.10 | 1-[3-[(3,5-dibromobenzyl)amino]propyl]-3-phenylurea | IC50 is 330 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)-4H-chromen-4-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)-4H-chromen-4-one | IC50 is 0.001 mM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)quinolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)quinolin-4(1H)-one | IC50 is below 0.3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2,4-dibromo-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2,4-dibromo-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is 9.7 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2,4-dibromo-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2,4-dibromo-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is 4.9 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2,4-dichloro-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2,4-dichloro-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2,4-dichloro-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2,4-dichloro-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2-bromo-4-chloro-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2-bromo-4-chloro-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2-bromo-4-chloro-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2-bromo-4-chloro-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2-bromo-6-ethoxy-4-methoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2-bromo-6-ethoxy-4-methoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is 7.0 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(2-bromo-6-ethoxy-4-methoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(2-bromo-6-ethoxy-4-methoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is 3.3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,4-dichlorobenzyl)amino]propyl]thio)quinolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,4-dichlorobenzyl)amino]propyl]thio)quinolin-4(1H)-one | IC50 is 680 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one | IC50 is 580 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-1H-indole-3-carbonitrile | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-1H-indole-3-carbonitrile | IC50 is 54 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-6-phenylpyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-6-phenylpyrimidin-4(1H)-one | IC50 is 0.001 mM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is 8.1 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)quinolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)quinolin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[2,3-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[2,3-d]pyrimidin-4(1H)-one | IC50 is 150 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is 3.9 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(5,7-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(5,7-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is 14 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(7-bromo-5-chloro-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(7-bromo-5-chloro-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is 8.2 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(7-bromo-5-chloro-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(7-bromo-5-chloro-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)quinazolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)quinazolin-4(1H)-one | IC50 is 17 nM | Staphylococcus aureus | |
6.1.1.10 | 2-([3-[(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-([3-[(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | 2-chloro-4-[(4-methoxybenzyl)oxy]quinoline | - |
Enterococcus faecalis | |
6.1.1.10 | 2-chloro-4-[(4-methoxybenzyl)oxy]quinoline | - |
Staphylococcus aureus | |
6.1.1.10 | 2-[3-[(3,4-dichlorobenzyl)amino]propoxy]quinolin-4(1H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 2-[3-[(3,4-dichlorobenzyl)amino]propoxy]quinolin-4(1H)-one | IC50 is 38 nM | Staphylococcus aureus | |
6.1.1.10 | 3-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)-1,4-dihydronaphthalen-1-ol | - |
Enterococcus faecalis | |
6.1.1.10 | 3-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)-1,4-dihydronaphthalen-1-ol | IC50 is 0.0018 mM | Staphylococcus aureus | |
6.1.1.10 | 4-methoxybenzyloxy-quinoline | - |
Enterococcus faecalis | |
6.1.1.10 | 4-methoxybenzyloxy-quinoline | - |
Staphylococcus aureus | |
6.1.1.10 | 5-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[3,2-b]pyridin-7(4H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 5-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[3,2-b]pyridin-7(4H)-one | IC50 is 4 nM | Staphylococcus aureus | |
6.1.1.10 | 6-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[2,3-b]pyridin-4(7H)-one | - |
Enterococcus faecalis | |
6.1.1.10 | 6-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[2,3-b]pyridin-4(7H)-one | IC50 is 6.2 nM | Staphylococcus aureus | |
6.1.1.10 | additional information | antibacterial potency of the inhibitors, structure-activity relationships, inhibition mechanism, the quinolone moiety of the right hand side pharmacophore is crucial for enzyme inhibition, overview | Enterococcus faecalis | |
6.1.1.10 | additional information | inhibition mechanism, the quinolone moiety of the right hand side pharmacophore is crucial for enzyme inhibition, overview | Enterococcus faecium | |
6.1.1.10 | additional information | antibacterial potency of the inhibitors, structure-activity relationships, inhibition mechanism, the quinolone moiety of the right hand side pharmacophore is crucial for enzyme inhibition, overview | Staphylococcus aureus | |
6.1.1.10 | additional information | inhibition mechanism, the quinolone moiety of the right hand side pharmacophore is crucial for enzyme inhibition, overview | Staphylococcus epidermidis | |
6.1.1.10 | N-(1,4-dihydroquinolin-2-yl)-N'-(2,3,5-trichlorobenzyl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-(1,4-dihydroquinolin-2-yl)-N'-(2,3,5-trichlorobenzyl)propane-1,3-diamine | IC50 is 0.0001 mM | Staphylococcus aureus | |
6.1.1.10 | N-(3,5-dibromobenzyl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-(3,5-dibromobenzyl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | IC50 is 5.0 nM | Staphylococcus aureus | |
6.1.1.10 | N-(6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-(6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Enterococcus faecium | |
6.1.1.10 | N-(6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | IC50 is 11 nM | Staphylococcus aureus | |
6.1.1.10 | N-(6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Staphylococcus epidermidis | |
6.1.1.10 | N-(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | IC50 is 18 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2,4-dibromo-6-ethoxybenzyl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2,4-dibromo-6-ethoxybenzyl)propane-1,3-diamine | IC50 is 17 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2,4-dichloro-6-ethoxybenzyl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2,4-dichloro-6-ethoxybenzyl)propane-1,3-diamine | IC50 is below 3 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2-bromo-4-chloro-6-ethoxybenzyl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2-bromo-4-chloro-6-ethoxybenzyl)propane-1,3-diamine | IC50 is 3.8 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2-bromo-6-ethoxy-4-methoxybenzyl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(2-bromo-6-ethoxy-4-methoxybenzyl)propane-1,3-diamine | IC50 is 17 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(3,5-dibromobenzyl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(3,5-dibromobenzyl)propane-1,3-diamine | IC50 is 29 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(5,7-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(5,7-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)propane-1,3-diamine | IC50 is 14 nM | Staphylococcus aureus | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)propane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-1H-benzimidazol-2-yl-N'-(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)propane-1,3-diamine | IC50 is 16 nM | Staphylococcus aureus | |
6.1.1.10 | N-[(4R)-6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl]-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-[(4R)-6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl]-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | IC50 is 6.3 nM | Staphylococcus aureus | |
6.1.1.10 | N-[(4S)-6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl]-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | - |
Enterococcus faecalis | |
6.1.1.10 | N-[(4S)-6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl]-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | IC50 is 48 nM | Staphylococcus aureus | |
6.1.1.10 | [3-[4-(4-Methoxy-benzyloxy)-quinolin-2-ylsulfanyl]-propyl]-carbamic acid tert-butyl ester | - |
Enterococcus faecalis | |
6.1.1.10 | [3-[4-(4-Methoxy-benzyloxy)-quinolin-2-ylsulfanyl]-propyl]-carbamic acid tert-butyl ester | - |
Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.1.1.10 | Enterococcus faecalis | - |
- |
- |
6.1.1.10 | Enterococcus faecium | - |
- |
- |
6.1.1.10 | Staphylococcus aureus | - |
- |
- |
6.1.1.10 | Staphylococcus epidermidis | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.1.1.10 | Methionyl tRNA synthetase | - |
Staphylococcus aureus |
6.1.1.10 | Methionyl tRNA synthetase | - |
Enterococcus faecalis |
6.1.1.10 | Methionyl tRNA synthetase | - |
Enterococcus faecium |
6.1.1.10 | Methionyl tRNA synthetase | - |
Staphylococcus epidermidis |
6.1.1.10 | MRS | - |
Staphylococcus aureus |
6.1.1.10 | MRS | - |
Enterococcus faecalis |
6.1.1.10 | MRS | - |
Enterococcus faecium |
6.1.1.10 | MRS | - |
Staphylococcus epidermidis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
6.1.1.10 | 0.0000003 | - |
IC50 is below 0.3 nM | Staphylococcus aureus | 2-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)quinolin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)quinolin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(2,4-dichloro-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(2,4-dichloro-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(2,4-dichloro-6-ethoxybenzyl)propane-1,3-diamine | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(2-bromo-4-chloro-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(2-bromo-4-chloro-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(7-bromo-5-chloro-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.000003 | - |
IC50 is below 3 nM | Staphylococcus aureus | 2-([3-[(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.0000033 | - |
IC50 is 3.3 nM | Staphylococcus aureus | 2-([3-[(2-bromo-6-ethoxy-4-methoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.0000038 | - |
IC50 is 3.8 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(2-bromo-4-chloro-6-ethoxybenzyl)propane-1,3-diamine | |
6.1.1.10 | 0.0000039 | - |
IC50 is 3.9 nM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.000004 | - |
IC50 is 4 nM | Staphylococcus aureus | 5-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[3,2-b]pyridin-7(4H)-one | |
6.1.1.10 | 0.0000049 | - |
IC50 is 4.9 nM | Staphylococcus aureus | 2-([3-[(2,4-dibromo-6-ethoxybenzyl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.000005 | - |
IC50 is 5.0 nM | Staphylococcus aureus | N-(3,5-dibromobenzyl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | |
6.1.1.10 | 0.0000062 | - |
IC50 is 6.2 nM | Staphylococcus aureus | 6-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[2,3-b]pyridin-4(7H)-one | |
6.1.1.10 | 0.0000063 | - |
IC50 is 6.3 nM | Staphylococcus aureus | N-[(4R)-6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl]-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | |
6.1.1.10 | 0.000007 | - |
IC50 is 7.0 nM | Staphylococcus aureus | 2-([3-[(2-bromo-6-ethoxy-4-methoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.0000081 | - |
IC50 is 8.1 nM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.0000082 | - |
IC50 is 8.2 nM | Staphylococcus aureus | 2-([3-[(7-bromo-5-chloro-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.0000097 | - |
IC50 is 9.7 nM | Staphylococcus aureus | 2-([3-[(2,4-dibromo-6-ethoxybenzyl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.000011 | - |
IC50 is 11 nM | Staphylococcus aureus | N-(6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | |
6.1.1.10 | 0.000014 | - |
IC50 is 14 nM | Staphylococcus aureus | 2-([3-[(5,7-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)thieno[3,2-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.000014 | - |
IC50 is 14 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(5,7-dibromo-1,2,3,4-tetrahydroquinolin-4-yl)propane-1,3-diamine | |
6.1.1.10 | 0.000016 | - |
IC50 is 16 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)propane-1,3-diamine | |
6.1.1.10 | 0.000017 | - |
IC50 is 17 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(2,4-dibromo-6-ethoxybenzyl)propane-1,3-diamine | |
6.1.1.10 | 0.000017 | - |
IC50 is 17 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(2-bromo-6-ethoxy-4-methoxybenzyl)propane-1,3-diamine | |
6.1.1.10 | 0.000017 | - |
IC50 is 17 nM | Staphylococcus aureus | 2-([3-[(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)amino]propyl]amino)quinazolin-4(1H)-one | |
6.1.1.10 | 0.000018 | - |
IC50 is 18 nM | Staphylococcus aureus | N-(7-ethyl-5-iodo-1,2,3,4-tetrahydroquinolin-4-yl)-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | |
6.1.1.10 | 0.000029 | - |
IC50 is 29 nM | Staphylococcus aureus | N-1H-benzimidazol-2-yl-N'-(3,5-dibromobenzyl)propane-1,3-diamine | |
6.1.1.10 | 0.000038 | - |
IC50 is 38 nM | Staphylococcus aureus | 2-[3-[(3,4-dichlorobenzyl)amino]propoxy]quinolin-4(1H)-one | |
6.1.1.10 | 0.000048 | - |
IC50 is 48 nM | Staphylococcus aureus | N-[(4S)-6,8-dibromo-1,2,3,4-tetrahydroquinolin-4-yl]-N'-1H-imidazo[4,5-b]pyridin-2-ylpropane-1,3-diamine | |
6.1.1.10 | 0.000054 | - |
IC50 is 54 nM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-1H-indole-3-carbonitrile | |
6.1.1.10 | 0.0001 | - |
IC50 is 0.0001 mM | Staphylococcus aureus | N-(1,4-dihydroquinolin-2-yl)-N'-(2,3,5-trichlorobenzyl)propane-1,3-diamine | |
6.1.1.10 | 0.00015 | - |
IC50 is 150 nM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)thieno[2,3-d]pyrimidin-4(1H)-one | |
6.1.1.10 | 0.00033 | - |
IC50 is 330 nM | Staphylococcus aureus | 1-[3-[(3,5-dibromobenzyl)amino]propyl]-3-phenylurea | |
6.1.1.10 | 0.00058 | - |
IC50 is 580 nM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one | |
6.1.1.10 | 0.00068 | - |
IC50 is 680 nM | Staphylococcus aureus | 2-([3-[(3,4-dichlorobenzyl)amino]propyl]thio)quinolin-4(1H)-one | |
6.1.1.10 | 0.001 | - |
IC50 is 0.001 mM | Staphylococcus aureus | 2-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)-4H-chromen-4-one | |
6.1.1.10 | 0.001 | - |
IC50 is 0.001 mM | Staphylococcus aureus | 2-([3-[(3,5-dibromobenzyl)amino]propyl]amino)-6-phenylpyrimidin-4(1H)-one | |
6.1.1.10 | 0.0018 | - |
IC50 is 0.0018 mM | Staphylococcus aureus | 3-([3-[(2,3,5-trichlorobenzyl)amino]propyl]amino)-1,4-dihydronaphthalen-1-ol |